We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01198470
Recruitment Status : Completed
First Posted : September 10, 2010
Results First Posted : October 2, 2018
Last Update Posted : October 2, 2018
Information provided by (Responsible Party):
Globus Medical Inc

Brief Summary:
The purpose of this investigation is to evaluate the safety and effectiveness of the TRIUMPH® Lumbar Artificial Disc for the treatment of patients who are suffering from Degenerative Disc Disease (DDD) at one level from L1 to S1.

Condition or disease Intervention/treatment Phase
Lumbar Degenerative Disc Disease Device: TRIUMPH® Lumbar Artificial Disc Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Prospective Clinical Investigation of the TRIUMPH Lumbar Disc: A Pilot Study
Study Start Date : September 2010
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

Drug Information available for: Iodine

Arm Intervention/treatment
Experimental: TRIUMPH® Artificial Disc
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
Device: TRIUMPH® Lumbar Artificial Disc
The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.

Primary Outcome Measures :
  1. Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at Baseline [ Time Frame: 24 months ]
    The Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting. It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale, 5 representing the greatest disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

  2. Number of Participants With No Device Failures [ Time Frame: 24 months ]
    Any device requiring surgical revision, reoperation, removal or supplemental fixation will be considered a device failure

  3. Number of Participants With Major Complications Defined as Major Vessel Injury or Neurological Damage [ Time Frame: 24 months ]
    Major vessel injury is defined as injury of the aorta or vena cava or other major vessels (e.g. iliac arteries, superior rectal artery, iliac veins, and their branches), caused by the surgery or device, resulting in significant blood loss or requiring additional surgery to correct. Neurological damage is defined as damage to the spinal cord or a nerve root caused by the surgery or device, resulting in neurologic deficit that persists for more than 3 months and is without improvement, is progressive, or involves motor loss. Major complications are reported on adverse event case report forms.

  4. Number of Participants Determined to Have a Normal Neurological Status [ Time Frame: 24 months ]

    Neurological status was assessed using a neurological status scale, which is based on four types of measurement parameters: motor, sensory, reflexes, and straight leg raise. The method for summarizing neurological status is described below. Each parameter (i.e. motor, sensory, reflexes, straight leg raise) is coded as follows:

    Motor 0 Total Paralysis

    1. Palpable or Visible Contraction
    2. Active Movement, Gravity Eliminated
    3. Active Movement, Against Gravity
    4. Active Movement, Against Some Resistance
    5. Active Movement, Against Full Resistance

    Sensory 0 Absent

    1. Impaired
    2. Normal

    Reflexes 0 Absent or Trace

    1. Hyper-reflexive
    2. Normal or hypo-reflexive

    Straight Leg Raise 0 0° - 70° (Abnormal)

    1 > 70°-90° (Normal)

    If all evaluations for the parameter are determined to be normal, then the parameter is given a normal status. If any evaluations for the parameter are abnormal, then the parameter is given an abnormal status.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Degenerative Disc Disease in one vertebral level between L1 and S1
  • Able to understand and sign informed consent
  • Had at least 6 months of conservative treatment
  • Oswestry Disability Index Score of at least 30 (one a 100 point scale)
  • Other inclusion criteria as specified in approved IDE protocol

Exclusion Criteria:

  • Bilateral leg pain
  • Back or leg pain of unknown etiology
  • Prior fusion surgery or another spinal device implanted at any other lumbar level
  • Osteoporosis or osteopenia
  • Other exclusion criteria as specified in approved IDE protocol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01198470

Layout table for location information
United States, Georgia
Memorial Health University Medical Center
Savannah, Georgia, United States, 31403
Sponsors and Collaborators
Globus Medical Inc
Layout table for additonal information
Responsible Party: Globus Medical Inc
ClinicalTrials.gov Identifier: NCT01198470    
Other Study ID Numbers: G090143
First Posted: September 10, 2010    Key Record Dates
Results First Posted: October 2, 2018
Last Update Posted: October 2, 2018
Last Verified: October 2018
Keywords provided by Globus Medical Inc:
Low back pain
Leg pain
Discogenic pain
Degenerative Disc Disease (DDD)
Herniated disc
Additional relevant MeSH terms:
Layout table for MeSH terms
Intervertebral Disc Degeneration
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases